Reuters logo
4 months ago
BRIEF-Shilpa Medicare says USFDA issued EIR for API manufacturing facilities at Raichur
April 12, 2017 / 6:30 AM / 4 months ago

BRIEF-Shilpa Medicare says USFDA issued EIR for API manufacturing facilities at Raichur

April 12 (Reuters) - Shilpa Medicare Ltd

* Says USFDA issued EIR for company's active pharmaceutical ingredient (API) manufacturing facilities located at Raichur

* Submitted a detailed corrective and preventive action (CAPA) plan to regulator within stipulated timelines in response to form 483

* Says inspection has now been closed by US FDA

* Says US FDA has reviewed CAPA and has found them acceptable Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below